Arteris (AIP) CFO sells 221,035 shares and exercises 213,021 options
Rhea-AI Filing Summary
Arteris, Inc. VP and Chief Financial Officer Nicholas B. Hawkins reported an exercise-and-sell sequence in company stock. On May 15, 2026, he exercised stock options covering 213,021 shares of common stock at exercise prices of $0.56 and $9.28 per share.
On the same date, he sold 221,035 shares of common stock in open-market transactions at weighted average prices ranging from about $32.18 to $34.65 per share, according to the footnotes. After these trades, he continues to hold more than 100,000 shares directly.
Positive
- None.
Negative
- None.
Insights
CFO exercised low-priced options and sold shares in routine liquidity trades.
Arteris VP and CFO Nicholas B. Hawkins exercised options for 213,021 shares at relatively low strike prices of $0.56 and $9.28. He then sold 221,035 common shares in open-market transactions at weighted average prices in the low-to-mid $30 range.
This pattern reflects a typical exercise-and-sell sequence where derivative awards convert into common stock and cash. There is no indication of a Rule 10b5-1 trading plan in the provided data, and no remaining option positions are shown in the derivative summary, suggesting these particular option grants were fully exercised.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Incentive Stock Option (right to buy) | 197,396 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (right to buy) | 15,625 | $0.00 | -- |
| Exercise | Common Stock | 197,396 | $0.56 | $111K |
| Exercise | Common Stock | 15,625 | $9.28 | $145K |
| Sale | Common Stock | 52,928 | $32.9749 | $1.75M |
| Sale | Common Stock | 164,916 | $33.5087 | $5.53M |
| Sale | Common Stock | 3,191 | $34.585 | $110K |
Footnotes (1)
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.18 to $33.175 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $33.18 to $33.98 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.42 to $34.65 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Incentive stock options, 25% of the total shares vested on November 11, 2020 and the remainder vesting 1/48th monthly thereafter for three years. Non-qualified stock options, vesting in 16 equal quarterly installments of 1/16th each, beginning on April 1, 2025.